How will brepocitinib cream compare with established treatments for mild-to-moderate eczema?

Br J Dermatol. 2022 Dec;187(6):838. doi: 10.1111/bjd.21880. Epub 2022 Oct 5.

Authors

Stephanie J Lax¹, Aaron M Drucker^{2

3}

Affiliations

¹ Centre of Evidence Based Dermatology, University of Nottingham, Nottingham, UK.
² Women's College Research Institute and Department of Medicine, Women's College Hospital, Toronto, ON, Canada.
³ Division of Dermatology, Department of Medicine, University of Toronto, Toronto, ON, Canada.

PMID: 36199210
DOI: 10.1111/bjd.21880

No abstract available

Publication types

Comment

MeSH terms

Eczema* / drug therapy
Emollients
Humans
Janus Kinase Inhibitors*

Substances

Emollients
Janus Kinase Inhibitors

Grants and funding

Research for Patient Benefit (NIHR201993)/National Institute for Health Research